相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
Mei Zhou et al.
CANCER RESEARCH (2014)
Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis
Marina G. Silveira et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Expression of Fibroblast Growth Factor 19 Is Associated with Recurrence and Poor Prognosis of Hepatocellular Carcinoma
Jiyeon Hyeon et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice
Iker Uriarte et al.
GUT (2013)
Bile acid transporters and regulatory nuclear receptors in the liver and beyond
Emina Halilbasic et al.
JOURNAL OF HEPATOLOGY (2013)
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Shin Yoshimoto et al.
NATURE (2013)
Altered enterohepatic circulation of bile acids in Crohn's disease and their clinical significance: a new perspective
Jonathan D. Nolan et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Circulating Fibroblast Growth Factors as Metabolic Regulators-A Critical Appraisal
Bo Angelin et al.
CELL METABOLISM (2012)
Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis
Salvatore Modica et al.
GASTROENTEROLOGY (2012)
Endocrine fibroblast growth factors 15/19 and 21: from feast to famine
Matthew J. Potthoff et al.
GENES & DEVELOPMENT (2012)
Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice
Bo Kong et al.
HEPATOLOGY (2012)
Emerging Role of Fibroblast Growth Factors 15/19 and 21 as Metabolic Integrators in the Liver
Claudia Cicione et al.
HEPATOLOGY (2012)
Primary biliary cirrhosis and cancer risk: A systematic review and meta-analysis
Yan Liang et al.
HEPATOLOGY (2012)
Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models
Dorothy M. French et al.
PLOS ONE (2012)
Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
Eric T. Sawey et al.
CANCER CELL (2011)
Alpha-Fetoprotein Should Be Included in the Hepatocellular Carcinoma Surveillance Guidelines of the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2011)
Bile Acid Malabsorption in Inflammatory Bowel Disease: Assessment by Serum Markers
Martin Lenicek et al.
INFLAMMATORY BOWEL DISEASES (2011)
FGF19 Regulates Cell Proliferation, Glucose and Bile Acid Metabolism via FGFR4-Dependent and Independent Pathways
Ai-Luen Wu et al.
PLOS ONE (2011)
Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches
Gideon M. Hirschfield et al.
GASTROENTEROLOGY (2010)
Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19)
Xinle Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Bile Acids: Trying to Understand Their Chemistry and Biology with the Hope of Helping Patients
Alan F. Hofmann
HEPATOLOGY (2009)
Bile Acids Activate Fibroblast Growth Factor 19 Signaling in Human Hepatocytes to Inhibit Cholesterol 7 alpha-Hydroxylase Gene Expression
Kwang-Hoon Song et al.
HEPATOLOGY (2009)
High Expression of the Bile Salt-Homeostatic Hormone Fibroblast Growth Factor 19 in the Liver of Patients with Extrahepatic Cholestasis
Frank G. Schaap et al.
HEPATOLOGY (2009)
Adenovirus-Adeno-Associated Virus Hybrid for Large-Scale Recombinant Adeno-Associated Virus Production
Hongwei Zhang et al.
HUMAN GENE THERAPY (2009)
Fifty years of advances in bile acid synthesis and metabolism
David W. Russell
JOURNAL OF LIPID RESEARCH (2009)
Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models
Lr Desnoyers et al.
ONCOGENE (2008)
Ursodeoxycholic acid for the treatment of primary biliary cirrhosis
Keith Lindor
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Hypercholesterolemia in primary biliary cirrhosis
Ta-Chen Su et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Co-receptor requirements for fibroblast growth factor-19 signaling
Xinle Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor Isoforms determines metabolic activity of FGF19 and FGF21
Hiroshi Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Liver-specific activities of FGF19 require Klotho beta
Benjamin C. Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy
Saskia W. C. Van Mil et al.
GASTROENTEROLOGY (2007)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
Medical progress: Primary biliary cirrhosis
MM Kaplan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Impaired negative feedback suppression of bile acid synthesis in mice lacking βKlotho
S Ito et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity
F Chen et al.
GASTROENTEROLOGY (2004)
Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis
JA Holt et al.
GENES & DEVELOPMENT (2003)
Monitoring hepatic cholesterol 7α-hydroxylase activity by assay of the stable bile acid intermediate 7α-hydroxy-4-cholesten-3-one in peripheral blood
C Gälman et al.
JOURNAL OF LIPID RESEARCH (2003)
Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
CR Pullingr et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
A mouse model of hepatocellular carcinoma - Ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice
K Nicholes et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors
AK Zaiss et al.
JOURNAL OF VIROLOGY (2002)
Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4
CD Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
